Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infiltrated erythematous plaques on the lumbar area.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2020
Same author

Merkel cell carcinoma: A review.

Journal of cutaneous pathology·2020
Same author

A case of spontaneous regression of metastatic skin undifferentiated carcinoma.

Italian journal of dermatology and venereology·2020
Same author

Cutaneous lymphohistiocytic infiltrates with foamy macrophages: A novel histopathological clue to Stenotrophomonas maltophilia septicemia.

Journal of cutaneous pathology·2020
Same author

Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients.

Blood advances·2020
Same author

A 47-Year-Old Patient With Multiple Desquamative Patches and Subsequent Onset of Papular Lesions: Answer.

The American Journal of dermatopathology·2020

Related Experiment Video

Updated: Jul 5, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

Drug reactions - new observations.

Ingrid H Wolf1, Peter Wolf, Lorenzo Cerroni

  • 1Department of Dermatology and Venerology, Medical University of Graz, Austria. ingrid.wolf@meduni-graz.at

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|May 23, 2008
PubMed
Summary

Two novel drug reactions in dermatology are presented: follicular eruption linked to Everolimus and sebaceous gland atrophy associated with Sirolimus. These findings highlight potential side effects of innovative immunosuppressants.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Jul 5, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Area of Science:

  • Dermatology
  • Pharmacology
  • Oncology

Background:

  • Innovative drugs, particularly immunosuppressants like mTOR inhibitors, are increasingly used in various medical fields.
  • Understanding the dermatological side effects of these novel therapeutics is crucial for patient management and treatment adherence.

Observation:

  • Two distinct clinical observations regarding drug-induced skin reactions are detailed.
  • Case 1: A patient developed a follicular eruption following treatment with Everolimus.
  • Case 2: Another patient exhibited atrophy of the sebaceous glands subsequent to Sirolimus therapy.

Findings:

  • Everolimus, an mTOR inhibitor, can induce a follicular drug eruption, a previously underreported reaction.
  • Sirolimus, another mTOR inhibitor, is associated with the development of sebaceous gland atrophy.
  • These findings underscore the varied and specific dermatological toxicities associated with mTOR inhibitors.

Implications:

  • Clinicians should be vigilant for follicular eruptions in patients treated with Everolimus.
  • The potential for Sirolimus to cause sebaceous gland atrophy warrants consideration in long-term treatment plans.
  • Further research into the mechanisms and management of these drug reactions is recommended to improve patient outcomes.